Benzodiazepine use and risk of Alzheimer's disease: case-control study
Given the debated association between long-term benzodiazepine use and dementia, does my expected duration on alprazolam keep me clearly in short-term territory?
Well-supported by good-quality research. how we score evidence
Caveat on this rating: Association, not proven causation - anxiety and insomnia can be early dementia symptoms that trigger benzodiazepine prescriptions years before diagnosis, and the prospective Gray 2016 cohort (BMJ) found no dose-response supporting a causal link.
Comparing 1,796 older adults with Alzheimer's disease against 7,184 matched controls, past benzodiazepine use beyond 3 months was associated with roughly 1.5-times higher odds of Alzheimer's, rising to 1.8-times with longer cumulative use.
Worth asking
Given the debated association between long-term benzodiazepine use and dementia, does my expected duration on alprazolam keep me clearly in short-term territory?
What it is FDA approved for
Read off the label. Trial duration and approval year are shown only where they were recorded — never inferred.
- Generalized anxiety disorder (acute treatment)
- Panic disorder, with or without agoraphobia
Source
Benzodiazepine use and risk of Alzheimer's disease: case-control study — Billioti de Gage S, et al. (2014)
Top-tier peer-reviewed journal
Read the source: https://doi.org/10.1136/bmj.g5205
DOI: 10.1136/bmj.g5205
How this was scored
- Study design
- Case-control study
- Funding
- Independently funded
- Published in
- Top-tier peer-reviewed journal
- Sample size
- 8,980
- Preregistered
- No
- Conflicts disclosed
- Yes
- Independent of proponent
- Yes
- Retracted
- No
Read the full scoring rubric, including what it can't tell you.
Published August 19, 2026.
Questions
How strong is the evidence behind this?
Resolv rates this source "strong evidence". Well-supported by good-quality research. It scores 72 out of 100 on our published rubric. One caveat travels with that badge: Association, not proven causation - anxiety and insomnia can be early dementia symptoms that trigger benzodiazepine prescriptions years before diagnosis, and the prospective Gray 2016 cohort (BMJ) found no dose-response supporting a causal link. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.
What is the source for this?
Benzodiazepine use and risk of Alzheimer's disease: case-control study — Billioti de Gage S, et al. (2014). Published in: Top-tier peer-reviewed journal. DOI: 10.1136/bmj.g5205. The full source is linked on this page so you can read it yourself.
Who paid for this research, and does that matter?
Study design: Case-control study. Funding: Independently funded. The researchers were independent of whoever benefits from the result. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.
Is alprazolam (Xanax), xanax FDA approved?
Yes — FDA approved for Generalized anxiety disorder (acute treatment), Panic disorder, with or without agoraphobia. Approval is for a specific indication, not for everything the drug is prescribed for.
Is this medical advice?
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.